MSD & Co and Moderna have advanced a combination of an mRNA-based cancer vaccine and checkpoint inhibitor Keytruda into a phase 3 trial in skin cancer melanoma, althou
Uniting technical mRNA specialists in Europe for the very first time, the inaugural mRNA Analytical Development Summit Europe will bring 80+ Analytical Development, CMC, Quality, and Regula
Moderna’s aspiration to become a player in the seasonal influenza vaccine market has hit a hurdle – likely a delay rather than anything more serious – but its stock has st
